Share

    


Home / Search Results

Search Results

Search Publications

Search Again?

Filter By Content Type

Filter By Topic

You searched for:

SOCIAL DRIVERS OF HEALTH PROVIDER SURVEY RESULTS: A FOCUS ON METASTATIC BREAST CANCER 1 BACKGROUND AND OVERVIEW Social drivers of health (SDOH) are individual factors that directly or indirectly influence a person’s health outcomes. Research shows that SDOH factors, including access to quality nutrition, stable housing, basic utilities, transportation, and an environment free from …
SO14-Ask-ACCC-Community-Resource-Centers-Pancreatic-Cancer
COVID-19 has brought an unexpected, unwelcome, and unwanted disruption to oncology care, as it has to every other facet of life. ACCC has met this unprecedented pandemic, however, with its characteristic “how to” approach.
Presented at the 2020 ASCO Quality Care Symposium.
JA05-What-to-Look-for-in-Your-Cancer-Program-Administrator
ACCC ONCOLOGY REIMBURSEMENT MEETINGS 2018 Billing & Coding Alternative Payment Models Data & Quality Reporting Federal Reimbursement Policies Financial Navigation Services REGISTER TODAY! ACCC-CANCER.ORG/ReimbursementMeeting FRIDAY, SEPTEMBER 21 Chicago Marriott Schaumburg Schaumburg, Illinois TUESDAY, NOVEMBER 13 The Dearborn Inn Dearborn, Michigan …
Take 5 minutes and read tips on how to lead with empathy, 10 Ted Lasso lessons for leaders, strategies for eliminating recruitment bias, and more.
Advancing CAR T-Cell Therapy Care Continuity and Collaborative Patient Education Working Summit Highlights ASSOCIATION OF CANCER CARE CENTERS Where We Are As of 2024, 6 chimeric antigen receptor (CAR) T-cell therapies have been approved by the Food and Drug Administration (FDA) to treat hematologic malignancies. However, a substantial percentage of patients eligible for CAR T-cell therapy …
Advancing CAR T-Cell Therapy Care Continuity and Collaborative Patient Education Working Summit Highlights ASSOCIATION OF CANCER CARE CENTERS Where We Are As of 2024, 6 chimeric antigen receptor (CAR) T-cell therapies have been approved by the Food and Drug Administration (FDA) to treat hematologic malignancies. However, a substantial percentage of patients eligible for CAR T-cell therapy …
State Medical Oncology Societies Full Terms & Conditions of access and use can be found at https://www.tandfonline.com/action/journalInformation?journalCode=uacc20 Oncology Issues ISSN: 1046-3356 (Print) 2573-1777 (Online) Journal homepage: https://www.tandfonline.com/loi/uacc20 State Medical Oncology Societies Their Role in the New Health Care Environment Jamie Young To cite …
MA08-A-Human-Centered-Information-System-for-Central-Cancer-Registries
JF12-Cancer-Survivorship-Programs
Keeping Your Balance in Changing Times Full Terms & Conditions of access and use can be found at https://www.tandfonline.com/action/journalInformation?journalCode=uacc20 Oncology Issues ISSN: 1046-3356 (Print) 2573-1777 (Online) Journal homepage: https://www.tandfonline.com/loi/uacc20 Keeping Your Balance in Changing Times Donald Jewler To cite this article: Donald Jewler …
PCP-UsToo
Prostate-Cancer-Principles-for-Managing-Advanced-Prostate-Cancer
Kajdic-Hodzic-Rifeta-San-Diego-2022-ORM Implementing and Growing Financial Navigation Services Rifeta Kajdic-Hodzic ACCC Program Manager Former Patient Financial Advocate St. Luke’s Cancer Institute Background: Financial Advocate, Counselor, & Navigator We use these titles differently across the nation to cover a multitude of roles and tasks: • Benefit verification …
Making the Business Case for Hiring a Financial Navigator By Lori Schneider and Christina Fuller In the U.S., cancer is one of the most expensive diseases to treat, second only to heart disease,1-3 and cancer-related expenses are rising.4-5 In fact, cancer patients experience a higher out-of-pocket financial burden than those with other chronic diseases.6 For people with cancer, figuring …
Making the Business Case for Hiring a Financial Navigator By Lori Schneider and Christina Fuller In the U.S., cancer is one of the most expensive diseases to treat, second only to heart disease,1-3 and cancer-related expenses are rising.4-5 In fact, cancer patients experience a higher out-of-pocket financial burden than those with other chronic diseases.6 For people with cancer, figuring …
Making the Business Case for Hiring a Financial Navigator By Lori Schneider and Christina Fuller In the U.S., cancer is one of the most expensive diseases to treat, second only to heart disease,1-3 and cancer-related expenses are rising.4-5 In fact, cancer patients experience a higher out-of-pocket financial burden than those with other chronic diseases.6 For people with cancer, figuring …
Findings from this study indicate that a Physical Activity Index may be a useful tool to facilitate productive patient-provider communication about physical activity goals.